Myelos: Reversing neurologic damage By Steve Edelson
Staff Writer

While most treatments for neurodegenerative diseases attempt to prevent disease or stave off disease progression, they are unable to reverse and repair damage caused by neurological disorders. Myelos Neurosciences Corp. is developing Prosaptide TX14(A), its lead compound, and second generation derivatives that the company says not only prevent neuronal death but also induce neuronal regeneration.